Basic Information (Switzerland) Elecon Asia SA (hereinafter referred to as “Elecon”) is a powerful intelligent three-d...
Digital Copyright Ten Major Typical Cases 1.Short Video Copyright Case: Whether a Short Video is Original Has Nothing to...
December 7, 2023 - News of a patent infringement ruling against Apple Watches a few weeks ago caused a flurry of investo...
The Saudi Authority for Intellectual Property received 5,837 patent applications at the domestic level and from abroad in 2022, it said in its annual report. The Saudi regulator noted that it
It's extremely unusual for the U.S. government to go after a pharmaceutical company for alleged patent infringement, much less take the case to trial. But in the government's case against Gilead
Canada-based natural gas bitcoin (BTC) miner Upstream Data has sued peer Crusoe Energy over patent infringement, according to court filings. The lawsuit claims that Crusoe's technology infringes on
Palo Alto, California-based international law firm Cooley and its client United Cannabis Corporation (UCANN) do not have to pay their opponent's legal fees in a patent lawsuit over CBD extraction
2020. It said in an amended 2021 complaint that several ArcherDX cancer tests violated its patent rights in technology for non-invasive cancer tests that use "cell-free DNA" from a patient's blood.
Patents need to be properly drafted to fulfill two requirements for a valid patent. Audrey Yap Su Ming, managing partner at Yusarn Audrey & Partners in Singapore, reiterated this key information in
patent infringement disputes happened to be foreign companies. CNIPA's work on the cases timely curbed infringing acts and sparked warm comments from the industry. As to cooperation and communication
Gene-sequencing giant Illumina Inc (ILMN.O) has settled a patent lawsuit brought by Maryland biotech company Ravgen Inc, which accused Illumina's genetic tests of infringing its patents. The
expected to face biosimilar competition. Tuesday, the industry got more information about when exactly that clash might occur. In J&J's patent case over Amgen's proposed biosimilar to J&J's Stelara, the
Energies and Atomic Energy Commission. Among them, the top five applicants with valid patent authorization are LG Group (668), Jinko Solar (666), AIKO Technology (609), CSIQ (555), and MAXEON SOLAR
CHINA intellectual PROPERTY LAWYERS NETWORK
+86-13910160652
ciplawyers@163.com
